{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:04:35Z","timestamp":1788282275220,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health\/National Institute of Allergy and Infectious Diseases","award":["R15 AR062883"],"award-info":[{"award-number":["R15 AR062883"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.intimp.2013.09.013","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T05:42:20Z","timestamp":1381383740000},"page":"894-906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cellular and urinary microRNA alterations in NZB\/W mice with hydroxychloroquine or prednisone treatment"],"prefix":"10.1016","volume":"17","author":[{"given":"Cristen B.","family":"Chafin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Regna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2013.09.013_bb0530","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00002281-200209000-00003","article-title":"Mediators of injury in lupus nephritis","volume":"14","author":"Oates","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0535","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0540","first-page":"849684","article-title":"Lupus nephritis: an overview of recent findings","volume":"2012","author":"de Zubiria Salgado","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.intimp.2013.09.013_bb0545","doi-asserted-by":"crossref","first-page":"579670","DOI":"10.1155\/2012\/579670","article-title":"Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis","volume":"2012","author":"Seret","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0550","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/JVI.79.1.17-27.2005","article-title":"Plasmacytoid dendritic cells: linking innate and adaptive immunity","volume":"79","author":"McKenna","year":"2005","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.intimp.2013.09.013_bb0555","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MNH.0b013e32832c9da2","article-title":"MicroRNAs and the kidney: coming of age","volume":"18","author":"Saal","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0040","doi-asserted-by":"crossref","first-page":"J207","DOI":"10.1016\/j.jaut.2009.12.006","article-title":"Epigenetics and autoimmunity","volume":"34","author":"Brooks","year":"2010","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.intimp.2013.09.013_bb0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.icb.7100091","article-title":"Fine-tuning of the innate immune response by microRNAs","volume":"85","author":"Gantier","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","article-title":"MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases","volume":"157","author":"Dai","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.intimp.2013.09.013_bb0560","article-title":"MicroRNA-126 regulates DNA methylation in CD4(+) T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1","author":"Zhao","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.intimp.2013.09.013_bb0065","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"10.1016\/j.intimp.2013.09.013_bb0070","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1073\/pnas.1200081109","article-title":"MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2013.09.013_bb0075","series-title":"Dubois' lupus erythematosus","year":"2002"},{"issue":"7","key":"10.1016\/j.intimp.2013.09.013_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/thorax.55.7.603","article-title":"Molecular mechanisms of glucocorticoid action: what is important?","volume":"55","author":"Newton","year":"2000","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1124\/mol.62.3.698","article-title":"Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages","volume":"62","author":"Korhonen","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0095","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0092-8674(90)90396-V","article-title":"Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein\u2013protein interaction","volume":"62","author":"Yang-Yen","year":"1990","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.intimp.2013.09.013_bb0100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/me.2011-0068","article-title":"Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms","volume":"25","author":"Flammer","year":"2011","journal-title":"Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.intimp.2013.09.013_bb0105","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0110","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/bbrc.2000.3922","article-title":"Glucocorticoid-induced apoptosis in lymphocytes","volume":"279","author":"Planey","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/JOE-11-0135","article-title":"Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells","volume":"211","author":"Schlossmacher","year":"2011","journal-title":"J Endocrinol"},{"issue":"20","key":"10.1016\/j.intimp.2013.09.013_bb0125","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1128\/MCB.00253-07","article-title":"Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor","volume":"27","author":"Lu","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0130","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrneph.2011.150","article-title":"The role of antimalarial agents in the treatment of SLE and lupus nephritis","volume":"7","author":"Lee","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.0019-2805.2001.01339.x","article-title":"Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells","volume":"105","author":"Jeong","year":"2002","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.85.3.839","article-title":"Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling","volume":"85","author":"Gonzalez-Noriega","year":"1980","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaci.2010.12.1087","article-title":"Current and novel therapeutics in the treatment of systemic lupus erythematosus","volume":"127","author":"Yildirim-Toruner","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11926-011-0186-6","article-title":"Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies","volume":"13","author":"Dall'era","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0155","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1073\/pnas.54.2.521","article-title":"Inhibition of DNA and RNA polymerase reactions by chloroquine","volume":"54","author":"Cohen","year":"1965","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0160","first-page":"87","article-title":"Effect of antimalarial treatment on circulating immune complexes in rheumatoid arthritis","volume":"12","author":"Segal-Eiras","year":"1985","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.intimp.2013.09.013_bb0165","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.HYP.0000243612.02929.df","article-title":"Insulin resistance and obesity in a mouse model of systemic lupus erythematosus","volume":"48","author":"Ryan","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0170","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1067\/mlc.2001.113755","article-title":"Lupus nephritis: lessons from experimental animal models","volume":"137","author":"Peutz-Kootstra","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2013.09.013_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.etp.2004.04.010","article-title":"Clinical and histopathological progression of lesions in lupus-prone (NZB\u00d7NZW) F1 mice","volume":"56","author":"Burnett","year":"2004","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus","volume":"37","author":"Theofilopoulos","year":"1985","journal-title":"Adv Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2249.1996.d01-839.x","article-title":"The treatment of systemic lupus erythematosus (SLE) in NZB\/WF1 hybrid mice; studies with recombinant murine DNase and with dexamethasone","volume":"106","author":"Macanovic","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0190","doi-asserted-by":"crossref","first-page":"e32424","DOI":"10.1371\/journal.pone.0032424","article-title":"SM934 treated lupus-prone NZB\u00d7NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development","volume":"7","author":"Hou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2013.09.013_bb0195","doi-asserted-by":"crossref","first-page":"465894","DOI":"10.1093\/ecam\/nen057","article-title":"An extract of antrodia camphorata mycelia attenuates the progression of nephritis in systemic lupus erythematosus-prone NZB\/W F1 mice","volume":"2011","author":"Chang","year":"2011","journal-title":"Evid Based Complement Altern Med"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.intimp.2003.12.006","article-title":"Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release","volume":"4","author":"Hong","year":"2004","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0205","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.intimp.2013.09.013_bb0210","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.48.7.542","article-title":"Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens","volume":"48","author":"Pavelka","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0215","first-page":"34","article-title":"Antimalarial drug induced decrease in creatinine clearance","volume":"22","author":"Landewe","year":"1995","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mai.2003.97","article-title":"Update on glucocorticoid action and resistance","volume":"111","author":"Leung","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.intimp.2013.09.013_bb0225","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.4049\/jimmunol.179.11.7941","article-title":"CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids","volume":"179","author":"Lee","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1083\/jcb.201208082","article-title":"Discovering the first microRNA-targeted drug","volume":"199","author":"Lindow","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0235","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.2147\/IJN.S37990","article-title":"MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice","volume":"7","author":"Pan","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1756-185X.12083","article-title":"MicroRNAs in the pathogenesis of systemic lupus erythematosus","volume":"16","author":"Ma","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0565","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2012.04.005","article-title":"miRNA in systemic lupus erythematosus","volume":"144","author":"Amarilyo","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0250","doi-asserted-by":"crossref","first-page":"430239","DOI":"10.1155\/2013\/430239","article-title":"MicroRNAs implicated in the immunopathogenesis of lupus nephritis","volume":"2013","author":"Chafin","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0570","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajpath.2011.04.021","article-title":"miR-21 and miR-214 are consistently modulated during renal injury in rodent models","volume":"179","author":"Denby","year":"2011","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.intimp.2013.09.013_bb0260","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/emmm.201100171","article-title":"Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice","volume":"3","author":"Garchow","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0265","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.4049\/jimmunol.0904060","article-title":"MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1","volume":"184","author":"Pan","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0270","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ki.2011.345","article-title":"Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation","volume":"81","author":"Ichii","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0275","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1440-1797.2012.01573.x","article-title":"Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis","volume":"17","author":"Lu","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0280","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0285","doi-asserted-by":"crossref","first-page":"e1002128","DOI":"10.1371\/journal.pgen.1002128","article-title":"A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus","volume":"7","author":"Luo","year":"2011","journal-title":"PLoS Genet"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0290","doi-asserted-by":"crossref","first-page":"e14302","DOI":"10.1371\/journal.pone.0014302","article-title":"Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus","volume":"5","author":"Dai","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0295","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0300","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10067-011-1857-4","article-title":"Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus","volume":"31","author":"Wang","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0305","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/08916934.2013.773976","article-title":"MicroRNA-let-7a expression is increased in the mesangial cells of NZB\/W mice and increases IL-6 production in vitro","volume":"46","author":"Chafin","year":"2013","journal-title":"Autoimmunity"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0310","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.51.12.1318","article-title":"Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis","volume":"51","author":"Morand","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.intimp.2013.09.013_bb0315","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/art.1780340803","article-title":"Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only","volume":"34","author":"Steinberg","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0320","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-352-3_1","article-title":"Isolation and propagation of glomerular mesangial cells","volume":"466","author":"Mene","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0330","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/art.24026","article-title":"Anti-alpha8 integrin immunoliposomes in glomeruli of lupus-susceptible mice: a novel system for delivery of therapeutic agents to the renal glomerulus in systemic lupus erythematosus","volume":"58","author":"Scindia","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0335","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/01913120600932594","article-title":"Plasticity of mesangial cells: a basis for understanding pathological alterations","volume":"30","author":"Herrera","year":"2006","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15321810500403755","article-title":"Impact of different cell isolation techniques on lymphocyte viability and function","volume":"27","author":"Klein","year":"2006","journal-title":"J Immunoass Immunochem"},{"issue":"11","key":"10.1016\/j.intimp.2013.09.013_bb0345","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1161\/ATVBAHA.112.251314","article-title":"Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice","volume":"32","author":"Macritchie","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.intimp.2013.09.013_bb0350","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2249.2008.03734.x","article-title":"Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes","volume":"154","author":"Velasquez-Lopera","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0355","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2008-04-152488","article-title":"Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation","volume":"112","author":"Dai","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0360","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/rheumatology\/kei282","article-title":"Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes\/macrophages by different modes","volume":"45","author":"Jang","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0365","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvn156","article-title":"Role of microRNAs in vascular diseases, inflammation, and angiogenesis","volume":"79","author":"Urbich","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0370","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3324\/haematol.2011.051730","article-title":"MicroRNAs are shaping the hematopoietic landscape","volume":"97","author":"Bissels","year":"2012","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0375","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/0961203307084158","article-title":"Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients","volume":"16","author":"Dai","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2013.09.013_bb0575","article-title":"Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients","author":"Dai","year":"2008","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0580","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0272-6386(97)90029-9","article-title":"Treatment of lupus nephritis: a meta-analysis of clinical trials","volume":"29","author":"Bansal","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.intimp.2013.09.013_bb0390","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.med.45.1.525","article-title":"The course and treatment of lupus nephritis","volume":"45","author":"Appel","year":"1994","journal-title":"Annu Rev Med"},{"issue":"10","key":"10.1016\/j.intimp.2013.09.013_bb0395","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: closing the gate on Toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.intimp.2013.09.013_bb0585","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","article-title":"Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.intimp.2013.09.013_bb0405","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.intimp.2013.09.013_bb0410","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"26","key":"10.1016\/j.intimp.2013.09.013_bb0590","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1182\/blood-2010-04-280156","article-title":"miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0420","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2222.2004.01824.x","article-title":"Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes","volume":"34","author":"Mozo","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.intimp.2013.09.013_bb0425","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/physiolgenomics.00160.2010","article-title":"MiRNA in innate immune responses: novel players in wound inflammation","volume":"43","author":"Roy","year":"2011","journal-title":"Physiol Genomics"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0430","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","article-title":"MicroRNAs in NF-kappaB signaling","volume":"3","author":"Ma","year":"2011","journal-title":"J Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.intimp.2013.09.013_bb0595","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/ncb1897","article-title":"TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN","volume":"11","author":"Kato","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0445","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"Mol Cell"},{"issue":"26","key":"10.1016\/j.intimp.2013.09.013_bb0450","doi-asserted-by":"crossref","first-page":"21783","DOI":"10.1074\/jbc.M112.355495","article-title":"DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion","volume":"287","author":"Niu","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.intimp.2013.09.013_bb0455","first-page":"803","article-title":"Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells","volume":"20","author":"Sperber","year":"1993","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.intimp.2013.09.013_bb0460","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood.V91.11.4255","article-title":"Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro","volume":"91","author":"Visser","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.09.013_bb0465","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1321.010","article-title":"Glucocorticoids and the Th1\/Th2 balance","volume":"1024","author":"Elenkov","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0470","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2013.09.013_bb0475","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.4049\/jimmunol.1101196","article-title":"Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression","volume":"188","author":"Swaminathan","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0600","doi-asserted-by":"crossref","DOI":"10.1038\/icb.2013.37","article-title":"MicroRNA-146a and RBM4 form a negative feed-forward loop that disrupts cytokine mRNA translation following TLR4 responses in human THP-1 monocytes","author":"Brudecki","year":"2013","journal-title":"Immunol Cell Biol"},{"issue":"33","key":"10.1016\/j.intimp.2013.09.013_bb0485","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0490","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s10753-012-9467-0","article-title":"Association of MicroRNA-146a with autoimmune diseases","volume":"35","author":"Xu","year":"2012","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.intimp.2013.09.013_bb0495","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1191\/096120301666080831","article-title":"Methotrexate therapy in systemic lupus erythematosus","volume":"10","author":"Sato","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2013.09.013_bb0500","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2164-8-166","article-title":"Characterization of microRNA expression profiles in normal human tissues","volume":"8","author":"Liang","year":"2007","journal-title":"BMC Genomics"},{"issue":"2","key":"10.1016\/j.intimp.2013.09.013_bb0505","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2011.04.033","article-title":"MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management","volume":"122","author":"Lu","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.intimp.2013.09.013_bb0605","article-title":"A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma","author":"Liu","year":"2013","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.intimp.2013.09.013_bb0515","doi-asserted-by":"crossref","first-page":"e10147","DOI":"10.1371\/journal.pone.0010147","article-title":"MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2","volume":"5","author":"Dong","year":"2010","journal-title":"PLoS One"},{"issue":"39","key":"10.1016\/j.intimp.2013.09.013_bb0520","doi-asserted-by":"crossref","first-page":"30139","DOI":"10.1074\/jbc.M110.145698","article-title":"Proinflammatory role for let-7 microRNAS in experimental asthma","volume":"285","author":"Polikepahad","year":"2010","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.intimp.2013.09.013_bb0525","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2012.02.016","article-title":"MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer","volume":"44","author":"Yamanaka","year":"2012","journal-title":"Dig Liver Dis"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T16:37:22Z","timestamp":1596645442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913003585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1567576913003585"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.09.013","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and urinary microRNA alterations in NZB\/W mice with hydroxychloroquine or prednisone treatment","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}